Peter DeMuth

CSO, Elicio Therapeutics
  • Elicio Therapeutics
  • United States of America

Subject

Applied Immunology and immunoengineering Biomolecular engineering Cancer technology Delivery of drugs, molecules or cells Drug and cell delivery Immunoengineering Molecular and cell engineering Nanobiotechnology Nanomedicine Nucleic acid therapies Translational medicine Vaccines

Topics

Channels contributed to:

Behind the Paper